GL1X · GenesisL1 explorer

MolNFT v1 · #126201 · protein

Crystal structure of human pcaf bromodomain in complex with compound-E (cpd-E)

5LVR · Histone acetyltransferase KAT2B: “Crystal structure of human pcaf bromodomain in complex with compound-E (cpd-E)”. X-ray diffraction, 1 ligand (78Y), 3 pockets (best druggability 0.67). MolNFT v1 #126201 on GenesisL1: 3D structure…

PDB
5LVR
Type
protein
Length
216 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase KAT2B
EC
2.3.1.48
UniProt
Q92831
Ligands
78Y
Pockets
3 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase KAT2B (EC 2.3.1.48)protein10866% helix, 0% strandQ92831
BHistone acetyltransferase KAT2B (EC 2.3.1.48)protein10870% helix, 0% strandQ92831

Ligands and binding sites

  • 78Y · 5-methyl-2-phenyl-1,2,3-triazole-4-carboxamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 6 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14840.670.7843empty
21080.570.8519EDO, DMS
31130.510.811978Y

Interfaces

1 interface between chains.

  • A–B · 810 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 5LVR · Crystal structure of human PCAF bromodomain in complex with compound-E (CPD-E) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92831 · AlphaFold monomer V2.0 prediction for histone acetyltransferase KAT2B (Q92831) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.